Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) was the target of a large decline in short interest in June. As of June 15th, there was short interest totaling 2,774 shares, a decline of 82.5% from the May 31st total of 15,871 shares. Based on an average daily volume of 38,408 shares, the days-to-cover ratio is currently 0.1 days.
Alpha Tau Medical Stock Up 24.5%
Alpha Tau Medical stock opened at $2.29 on Friday. The firm’s fifty day moving average price is $1.81 and its two-hundred day moving average price is $1.17. Alpha Tau Medical has a 1-year low of $0.20 and a 1-year high of $2.99.
About Alpha Tau Medical
Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.
The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.
Recommended Stories
- Five stocks we like better than Alpha Tau Medical
- BlackBerry’s Rally Is Running on a Bigger AI Story Than Earnings Alone
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
